Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
Butylphthalide soft capsule has been confirmed to have beneficial effects for patients with
vascular dementia (VaD) in clinical trial of phase II study. So the investigators hypothesize
that Butylphthalide soft capsule may have same beneficial effects for patients with VaD in an
extended samples in phase III study. In present study the investigators will recruit patients
with mild to moderate VaD in a multi-center, random, double blind and placebo control methods
to confirm the efficacy and safety of Butylphthalide soft capsule. The outcome measures
include general cognitive function, executive function, daily living skills, and mental
behavior changes of symptoms in VaD patients.